Subscribe To
Inmune (inmb) begins dosing in mid-stage study with ad candidate
INmune (INMB) doses the first patient in a phase II study with its investigational TNF inhibitor to treat Alzheimer's disease. Stock rises more than 1...
April 14, 2022, 5:19 pm
Valneva shares jump as its covid-19 vaccine receives conditional approved in uk
The Healthcare products Regulatory Agency (MHRA) of the U.K. has granted Conditional Marketing Authorization for Valneva SE's (NASDAQ: VALN)COVID-...
April 14, 2022, 8:41 am
Fda intends to revoke protagonist therapeutics' rusfertide breakthrough tag in rare form of blood cancer
Protagonist Therapeutics Inc (NASDAQ: PTGX) received a letter from the FDA indicating the agency's intent to rescind Breakthrough Therapy Designati...
April 14, 2022, 6:33 am
Biohaven pharmaceutical: recent growth will continue
Biohaven Pharmaceutical has a significant portfolio of innovative product candidates across neurologica...
April 14, 2022, 4:23 am
Bull of the day: the buckle, inc. (bke)
The Buckle runs a financially sound operation, alongside a high dividend yield that helps make it a solid cand...
April 13, 2022, 6:02 am
Dell technologies is a great value investment candidate. the price target is $60
Dell Technologies Inc. (NYSE:DELL) is a stock to watch in the computer hardware industry. Last week, it emerged that Dell's peer in the industry, HP I...
April 12, 2022, 2:21 pm
Cocrystal pharma posts favorable preliminary data from influenza a antiviral candidate trial
Cocrystal Pharma Inc (NASDAQ: COCP) reported preliminary results of a Phase 1 study with CC-42344, a broad-spectrum oral antiviral to treat pandemi...
April 12, 2022, 11:08 am
Ocugen stock drops after fda places clinical hold on study of covid-19 vaccine candidate covaxin
Shares of Ocugen Inc. OCGN, -2.03% sank 6.9% premarket, after the biotechnology company said the U.S. Food and Drug Administration placed a "clinical ...
April 12, 2022, 9:11 am
Here's why bicycle therapeutics stock looks ill today
Lackluster clinical trial results for its lead candidate are to blame....
April 11, 2022, 11:57 am
Why veru stock is surging today
Veru Inc (NASDAQ: VERU) shares are trading significantly higher Monday after the company reported its novel COVID-19 drug ...
April 11, 2022, 10:50 am
5 short squeeze candidates to watch: aterian tops the list, system1 group and longeveron join leaderboard
Potential short squeeze plays gained steam in 2021, with new retail traders looking for the next huge move. A short squeeze can occur when a heavily s...
April 11, 2022, 10:34 am
Blue water vaccines inc to present at world vaccine congress washington 2022
CINCINNATI, April 11, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or “the Company”) a biopharmaceuti...
April 11, 2022, 9:56 am
Moderna begins dosing participants in a phase 1/2 trial for its flu vaccine candidates
Shares of Moderna Inc. MRNA, +1.16% were down 1.3% in premarket trading on Monday after the company said it began dosing participants in a Phase 1/2 s...
April 11, 2022, 8:37 am
Could this drug candidate be a blockbuster for sanofi?
The pharma giant recently shared encouraging results from a late-stage clinical trial for its hemophilia drug ...
April 9, 2022, 11:45 am
Jazz inks deal with werewolf to add oncology candidate
Jazz (JAZZ) signs an agreement to gain rights to Werewolf's engineered cytokine pro-drug candidate WTX-...
April 8, 2022, 3:48 pm
Johnson & johnson vs. abbvie: why we hold abbvie
Both Johnson & Johnson and AbbVie are excellent candidates for our barbell strategy to build an endurin...
April 8, 2022, 5:50 am
Adverum (advm) up on fda feedback for gene therapy study
Adverum (ADVM) to submit IND amendment to the FDA by mid-2022 for starting a mid-stage study on its gene therapy ...
April 7, 2022, 4:34 pm
Minerva outlines next steps for us application for schizophrenia candidate
Minerva Neurosciences Inc (NASDAQ: NERV) received the official meeting minutes from the Type C meeting with the FDA regarding the development of ro...
April 7, 2022, 1:01 pm
Jazz, werewolf sign licensing deal worth up to $1.2 billion
Shares of Werewolf Therapeutics Inc. jumped 10.8% in premarket trading on Thursday after the company announced a licensing deal with Jazz Pharmaceutic...
April 7, 2022, 8:34 am
Recruiter.com group says deel partnership expands into new talent marketplace
Recruiter.com Group, Inc. (NASDAQ:RCRT) announced that it will be one of a select few companies included in Deel's exclusive new Talent Marketplace. O...
April 6, 2022, 11:28 am